東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Venture capital and the European bio...

Bains, William, (1955-)

Linked to FindBook

Google Book

Amazon

博客來

Venture capital and the European biotechnology industry

Record Type:	Electronic resources : Monograph/item
Title/Author:	Venture capital and the European biotechnology industry/ William Bains.
Author:	Bains, William,
Published:	Basingstoke [England] ;Palgrave Macmillan, : 2009.,
Description:	1 online resource (viii, 220 p.) :ill.
Notes:	Description based on print version record.
[NT 15003449]:	Introduction : the facts -- The biotechnology industry and venture capital -- Europe falls behind -- Why does Europe do so poorly? Some inadequate explanations -- Under-investment in European biotechnology -- Public markets and under-investment -- VC management of companies -- VC effects on business efficacy -- Investor blockade of business -- Pomp and circumstances -- The real VC business model -- What to do about it: government -- What to do about it: business -- References -- Index.
Subject:	Biotechnology industries - Finance. - Europe -
Online resource:	http://link.springer.com/10.1057/9780230227262access to fulltext (Palgrave)
ISBN:	0230227260 (electronic bk.)

Venture capital and the European biotechnology industry
Bains, William,1955-

Venture capital and the European biotechnology industry[electronicresource] /William Bains. - Basingstoke [England] ;Palgrave Macmillan,2009. - 1 online resource (viii, 220 p.) :ill.

Description based on print version record.

Includes bibliographical references (p. 201-215) and indexes.

Introduction : the facts -- The biotechnology industry and venture capital -- Europe falls behind -- Why does Europe do so poorly? Some inadequate explanations -- Under-investment in European biotechnology -- Public markets and under-investment -- VC management of companies -- VC effects on business efficacy -- Investor blockade of business -- Pomp and circumstances -- The real VC business model -- What to do about it: government -- What to do about it: business -- References -- Index.

Why do so many European biotechnology companies fail? This book finds an answer in the behavior of the investors who dominate the industry and control the behavior of the companies they invest in. Starting froma detailed analysis of the history of the industry from its earliest days, this book cuts through the hype and mythology to identify what really happened to the biotechnology industryin Europe, what went wrong with the business, the management and the investment, and who are the controlling figures that made it happen. Bains uses real case studies anda wealth of statistical data to show how systematic under-investment and extraordinary business decisions have made European companies stunted mimics of their US counterparts. Building on an inside knowledge of how venture capital really works, he shows how this is not an accidentalside-product of European inexperience or lack of business acumen, but a necessary result of how venture capitalists run their businesses in Europe. This is an essential book for entrepreneurs, investors and policy-makers alike, as well as being avaluable information source for anyone interested in how high-tech businesses are created.

ISBN: 0230227260 (electronic bk.)Subjects--Topical Terms:

1097860
Biotechnology industries
--Finance.--EuropeIndex Terms--Genre/Form:

542853
Electronic books.

LC Class. No.: HD9999.B443 / E85125 2009eb

Dewey Class. No.: 660.6068/1

Venture capital and the European biotechnology industry
LDR:02704cmm 2200301 a 45 001 911444
003 OCoLC
005 20110114
006 m d
007 cr cnu---unuuu
008 231227s2009 enka sb 001 0 eng d
020 $a 0230227260 (electronic bk.)
020 $a 9780230227262 (electronic bk.)
035 $a (OCoLC)319175573
035 $a ocn319175573
035 $a 911444
040 $a UKPGM $b eng $c UKPGM $d YDXCP $d N $t $d EBLCP $d CUS
043 $a e------
049 $a APTA
050 4 $a HD9999.B443 $b E85125 2009eb
082 0 4 $a 660.6068/1 $2 22
100 1 $a Bains, William, $d 1955- $3 600629
245 1 0 $a Venture capital and the European biotechnology industry $h [electronicresource] / $c William Bains.
260 $a Basingstoke [England] ; $a New York : $c 2009. $b Palgrave Macmillan,
300 $a 1 online resource (viii, 220 p.) : $b ill.
500 $a Description based on print version record.
504 $a Includes bibliographical references (p. 201-215) and indexes.
505 0 $a Introduction : the facts -- The biotechnology industry and venture capital -- Europe falls behind -- Why does Europe do so poorly? Some inadequate explanations -- Under-investment in European biotechnology -- Public markets and under-investment -- VC management of companies -- VC effects on business efficacy -- Investor blockade of business -- Pomp and circumstances -- The real VC business model -- What to do about it: government -- What to do about it: business -- References -- Index.
520 $a Why do so many European biotechnology companies fail? This book finds an answer in the behavior of the investors who dominate the industry and control the behavior of the companies they invest in. Starting froma detailed analysis of the history of the industry from its earliest days, this book cuts through the hype and mythology to identify what really happened to the biotechnology industryin Europe, what went wrong with the business, the management and the investment, and who are the controlling figures that made it happen. Bains uses real case studies anda wealth of statistical data to show how systematic under-investment and extraordinary business decisions have made European companies stunted mimics of their US counterparts. Building on an inside knowledge of how venture capital really works, he shows how this is not an accidentalside-product of European inexperience or lack of business acumen, but a necessary result of how venture capitalists run their businesses in Europe. This is an essential book for entrepreneurs, investors and policy-makers alike, as well as being avaluable information source for anyone interested in how high-tech businesses are created.
650 0 $a Biotechnology industries $z Europe $x Finance. $3 1097860
650 0 $a Venture capital. $3 645808
655 7 $a Electronic books. $2 lcsh $3 542853
856 4 0 $3 Palgrave Connect $u http://link.springer.com/10.1057/9780230227262 $z access to fulltext (Palgrave)